Cullinan Therapeutics, Inc. (CGEM) › RevenueCullinan Therapeutics, Inc. (CGEM) — RevenueAnnual figures by fiscal year, from SEC filings.2020: $02021: $18.94M2022: $0$02020Revenue (USD)2022Fiscal YearRevenueChange YoY2022$0-100.0%2021$18.94M—2020$0—Other metrics: Cost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share